Clinical Trial Update: Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies [NA]

View source ↗

Summary

A completed clinical trial comparing Yttrium-90 absorbed dose measurements between PET/CT and PET/MR imaging for hepatic malignancies; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Malignancies

Drugs mentioned

• Yttrium-90 (yttrium-90)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Hepatic Malignancies | NA | Status: COMPLETED | Results posted: 2021-10-05